This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pervin, S. Articles by Chaudhuri, G. Search for Related Content PubMed PubMed Citation Articles by Pervin, S. Articles by Chaudhuri, G.

Nitric Oxide in Physiologic Concentrations Targets the Translational Machinery to Increase the Proliferation of Human Breast Cancer Cells: Involvement of Mammalian Target of Rapamycin/eIF4E Pathway

¹ Departments of Obstetrics and Gynecology and Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California at Los Angeles; ² Division of Endocrinology and RCMI Molecular Medicine Core Laboratory at Charles R. Drew University of Science and Medicine; ³ Jonsson Comprehensive Cancer Center, Los Angeles, California; and ⁴ Department of Animal Sciences, Texas A&M University, College Station, Texas

Requests for reprints: Gautam Chaudhuri, Department of Obstetrics and Gynecology, David Geffen School of Medicine at University of California at Los Angeles, 27-117 CHS, 10833 Le Conte Avenue, Los Angeles, CA. Phone: 310-206-6575; Fax: 310-206-2057; E-mail: gchaudhuri{at}mednet.ucla.edu.

Nitric oxide (NO) in nanomolar (nmol/L) concentrations is consistently detected in tumor microenvironment and has been found to promote tumorigenesis. The mechanism by which NO enhances tumor progression is largely unknown. In this study, we investigated the possible mechanisms and identified cellular targets by which NO increases proliferation of human breast cancer cell lines MDA-MB-231 and MCF-7. DETA-NONOate, a long acting NO donor, with a half-life of 20 h, was used. We found that NO (nmol/L) dramatically increased total protein synthesis in MDA-MB-231 and MCF-7 and also increased cell proliferation. NO specifically increased the translation of cyclin D1 and ornithine decarboxylase (ODC) without altering their mRNA levels or half-lives. Critical components in the translational machinery, such as phosphorylated mammalian target of rapamycin (mTOR) and its downstream targets, phosphorylated eukaryotic translation initiation factor and p70 S6 kinase, were up-regulated following NO treatment, and inhibition of mTOR with rapamycin attenuated NO induced increase of cyclin D1 and ODC. Activation of translational machinery was mediated by NO-induced up-regulation of the Raf/mitogen-activated protein/extracellular signal-regulated kinase (ERK) kinase/ERK (Raf/MEK/ERK) and phosphatidylinositol 3-kinase (PI-3 kinase)/Akt signaling pathways. Up-regulation of the Raf/MEK/ERK and PI-3 kinase/Akt pathways by NO was found to be mediated by activation of Ras, which was cyclic guanosine 3',5'-monophosphate independent. Furthermore, inactivation of Ras by farnesyl transferase inhibitor or K-Ras small interfering RNA attenuated NO-induced increase in proliferation signaling and cyclin D1 and ODC translation, further confirming the involvement of Ras activation during NO-induced cell proliferation. [Cancer Res 2007;67(1):289–99]

This article has been cited by other articles:

				S. Pervin, A. H. Tran, S. Zekavati, J. M. Fukuto, R. Singh, and G. Chaudhuri Increased Susceptibility of Breast Cancer Cells to Stress Mediated Inhibition of Protein Synthesis Cancer Res., June 15, 2008; 68(12): 4862 - 4874. [Abstract] [Full Text] [PDF]

				L. H. Wei, Y. Yang, G. Wu, and L. J. Ignarro IL-4 and IL-13 upregulate ornithine decarboxylase expression by PI3K and MAP kinase pathways in vascular smooth muscle cells Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1198 - C1205. [Abstract] [Full Text] [PDF]

				N. Yeager, C. Brewer, K. Q. Cai, X.-X. Xu, and A. Di Cristofano Mammalian Target of Rapamycin Is the Key Effector of Phosphatidylinositol-3-OH Initiated Proliferative Signals in the Thyroid Follicular Epithelium Cancer Res., January 15, 2008; 68(2): 444 - 449. [Abstract] [Full Text] [PDF]

				B. A. Corl, J. Odle, X. Niu, A. J. Moeser, L. A. Gatlin, O. T. Phillips, A. T. Blikslager, and J. M. Rhoads Arginine Activates Intestinal p70S6k and Protein Synthesis in Piglet Rotavirus Enteritis J. Nutr., January 1, 2008; 138(1): 24 - 29. [Abstract] [Full Text] [PDF]

				L. Ying, A. B. Hofseth, D. D. Browning, M. Nagarkatti, P. S. Nagarkatti, and L. J. Hofseth Nitric Oxide Inactivates the Retinoblastoma Pathway in Chronic Inflammation Cancer Res., October 1, 2007; 67(19): 9286 - 9293. [Abstract] [Full Text] [PDF]

				C. Brewer, N. Yeager, and A. Di Cristofano Thyroid-Stimulating Hormone Initiated Proliferative Signals Converge In vivo on the mTOR Kinase without Activating AKT Cancer Res., September 1, 2007; 67(17): 8002 - 8006. [Abstract] [Full Text] [PDF]